112 related articles for article (PubMed ID: 15975539)
1. Selective granulocyte and monocyte apheresis as a new adjunct to enhance the efficacy of interferon-alpha + ribavirin in patients with high plasma hepatitis C virus.
Sawada K; Kashiwamura S; Okamura H; Ohnishi K; Fukunaga K; Hirata I; Saniabadi A
Dig Liver Dis; 2005 Jul; 37(7):515-21. PubMed ID: 15975539
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory effects of selective leucocytapheresis as a new adjunct to interferon-alpha2b plus ribavirin combination therapy: a prospective study in patients with high plasma HCV viraemia.
Sawada K; Masaki N; Hayashi S; Zeniya M; Ishikawa T; Takahashi H; Ohnishi K; Fukunaga K; Hara N; Yamamoto T; Hada T; Toda G
J Viral Hepat; 2005 May; 12(3):274-82. PubMed ID: 15850468
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte and monocyte adsorptive apheresis for patients with chronic hepatitis C virus infection: a report on six cases with high plasma viremia.
Sawada K; Ohnishi K; Fukunaga K; Kusaka T; Ohdo M; Nagase K; Shimoyama T; Hada T
Ther Apher Dial; 2003 Dec; 7(6):547-53. PubMed ID: 15018242
[TBL] [Abstract][Full Text] [Related]
4. High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline viral load.
Tsubota A; Arase Y; Suzuki F; Suzuki Y; Akuta N; Hosaka T; Someya T; Kobayashi M; Saitoh S; Ikeda K; Kumada H
J Gastroenterol; 2004; 39(2):155-61. PubMed ID: 15069622
[TBL] [Abstract][Full Text] [Related]
5. Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes.
Saniabadi AR; Hanai H; Takeuchi K; Umemura K; Nakashima M; Adachi T; Shima C; Bjarnason I; Lofberg R
Ther Apher Dial; 2003 Feb; 7(1):48-59. PubMed ID: 12921115
[TBL] [Abstract][Full Text] [Related]
6. High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study.
da Silva LC; Bassit L; Ono-Nita SK; Pinho JR; Nishiya A; Madruga CL; Carrilho FJ
J Gastroenterol; 2002; 37(9):732-6. PubMed ID: 12375147
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting clinical and endoscopic efficacies of selective leucocytapheresis for ulcerative colitis.
Yamamoto T; Saniabadi AR; Maruyama Y; Umegae S; Matsumoto K
Dig Liver Dis; 2007 Jul; 39(7):626-33. PubMed ID: 17532273
[TBL] [Abstract][Full Text] [Related]
8. Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin.
Gallegos-Orozco JF; Fuentes AP; Olivera-Martinez MA; Gutiérrez-Reyes G; Cortina D; Oregel JA; Pérez-Pruna C; Sixtos MS; Cruz-Castellanos S; Soto-Ramírez LE; Rodríguez-Díaz R; Fuentes-Romero L; Gutiérrez-Ruiz MC; Kershenobich D
Rev Invest Clin; 2003; 55(2):138-42. PubMed ID: 12827916
[TBL] [Abstract][Full Text] [Related]
9. Treatment effects and predictors of a 24-week course of interferon alpha-2b plus ribavirin combination therapy for patients with chronic hepatitis C.
Tomimatsu M; Aizawa Y; Chuganji Y; Ishizuka H; Fujita Y; Aizawa R; Abe H; Matsuda T; Itou Y; Nakanishi H; Ushiyama H; Higuchi T; Fujimoto T; Endou H; Iga D; Ohta K; Kuroda H
J Gastroenterol Hepatol; 2006 Jul; 21(7):1177-83. PubMed ID: 16824072
[TBL] [Abstract][Full Text] [Related]
10. Treatment of genotype 1b HCV-related chronic hepatitis: efficacy and toxicity of three different interferon alfa-2b/ribavirin combined regimens in naive patients.
Scotto G; Fazio V; Palumbo E; Cibelli DC; Saracino A; Angarano G
New Microbiol; 2005 Jan; 28(1):23-9. PubMed ID: 15782623
[TBL] [Abstract][Full Text] [Related]
11. Helper T cell cytokine response to ribavirin priming before combined treatment with interferon alpha and ribavirin for patients with chronic hepatitis C.
Furusyo N; Kubo N; Toyoda K; Takeoka H; Nabeshima S; Murata M; Nakamuta M; Hayashi J
Antiviral Res; 2005 Jul; 67(1):46-54. PubMed ID: 15913800
[TBL] [Abstract][Full Text] [Related]
12. Leucocytapheresis with Adacolumn enhances HCV-specific proliferative responses in patients infected with hepatitis C virus genotype 1.
Diepolder HM; Kashiwagi N; Teuber G; Ulsenheimer A; Franz M; Yokoyama T; Zachoval R
J Med Virol; 2005 Oct; 77(2):209-15. PubMed ID: 16121358
[TBL] [Abstract][Full Text] [Related]
13. Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin.
Bronowicki JP; Ouzan D; Asselah T; Desmorat H; Zarski JP; Foucher J; Bourlière M; Renou C; Tran A; Melin P; Hézode C; Chevalier M; Bouvier-Alias M; Chevaliez S; Montestruc F; Lonjon-Domanec I; Pawlotsky JM
Gastroenterology; 2006 Oct; 131(4):1040-8. PubMed ID: 17030174
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis.
Kanke K; Nakano M; Hiraishi H; Terano A
Dig Liver Dis; 2004 Dec; 36(12):811-7. PubMed ID: 15646427
[TBL] [Abstract][Full Text] [Related]
15. Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers.
Senturk H; Tahan V; Canbakan B; Uraz S; Ulger Y; Ozaras R; Tabak F; Mert A; Ozbay G
Neth J Med; 2008 May; 66(5):191-5. PubMed ID: 18490796
[TBL] [Abstract][Full Text] [Related]
16. Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C.
von Wagner M; Huber M; Berg T; Hinrichsen H; Rasenack J; Heintges T; Bergk A; Bernsmeier C; Häussinger D; Herrmann E; Zeuzem S
Gastroenterology; 2005 Aug; 129(2):522-7. PubMed ID: 16083709
[TBL] [Abstract][Full Text] [Related]
17. The preliminary efficacy of interferon-alpha and ribavirin combination treatment of chronic hepatitis C in HIV-infected patients.
Zheng YH; Zhang CY; He Y; Zhou HY; Zou W; Ding PP; Huang L; Li H
Chin Med J (Engl); 2005 Jul; 118(14):1195-200. PubMed ID: 16117865
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C.
McHutchison JG; Poynard T
Semin Liver Dis; 1999; 19 Suppl 1():57-65. PubMed ID: 10349693
[TBL] [Abstract][Full Text] [Related]
19. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J
N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of high-dose interferon in combination with ribavirin in patients with chronic hepatitis C resistant to interferon alone.
Min AD; Jones JL; Esposito S; Lebovics E; Jacobson IM; Klion FM; Goldman IS; Geders JM; Tobias H; Bodian C; Bodenheimer HC
Am J Gastroenterol; 2001 Apr; 96(4):1143-9. PubMed ID: 11316161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
